These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2152975)

  • 21. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estrogen therapy and breast cancer].
    Kannengiesser U; Völker W; Majewski A
    Arch Gynecol; 1979 Jul; 228(1-4):450-1. PubMed ID: 226007
    [No Abstract]   [Full Text] [Related]  

  • 23. [Estrogen therapy in carcinoma of the breast (author's transl)].
    Völker W; Kannengiesser U; Majewski A
    Geburtshilfe Frauenheilkd; 1980 Feb; 40(2):125-32. PubMed ID: 6245009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 25. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial.
    Rohan TE; Negassa A; Chlebowski RT; Habel L; McTiernan A; Ginsberg M; Wassertheil-Smoller S; Page DL
    J Natl Cancer Inst; 2008 Apr; 100(8):563-71. PubMed ID: 18398105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
    Vassilopoulou-Sellin R; Theriault RL
    J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of osteoporosis with estrogen].
    Mizunuma H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():397-403. PubMed ID: 15035159
    [No Abstract]   [Full Text] [Related]  

  • 29. Are lower doses of estrogen effective against osteoporosis?
    Healthc Demand Dis Manag; 1999 Aug; 5(8):125-7. PubMed ID: 10557953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy?
    Holtorf K
    Postgrad Med; 2009 Jan; 121(1):73-85. PubMed ID: 19179815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone replacement therapy and breast cancer].
    Mueck AO
    Med Monatsschr Pharm; 2002 Oct; 25(10):337-47. PubMed ID: 12404946
    [No Abstract]   [Full Text] [Related]  

  • 33. Hormone replacement therapy and breast cancer.
    Ramsey-Stewart G
    Med J Aust; 1993 Mar; 158(6):436. PubMed ID: 8479368
    [No Abstract]   [Full Text] [Related]  

  • 34. Conjugated estrogens and breast cancer risk.
    Campagnoli C; Ambroggio S; Biglia N; Sismondi P
    Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():13-9. PubMed ID: 10862264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The combination on conjugated estrogens and medroxyprogesterone in the post-menopause patient and risk of breast cancer: analysis of an uncertain statistic].
    Palma-Aguirre JA; del-Razo OE
    Gac Med Mex; 2002; 138(6):591-2. PubMed ID: 12532627
    [No Abstract]   [Full Text] [Related]  

  • 36. HT and WHI: the baby and the bathwater.
    Danby FW
    Climacteric; 2004 Mar; 7(1):112. PubMed ID: 15259290
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormone replacement therapy and breast cancer: an overview.
    Theriault RL
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():87-90; discussion 90-1. PubMed ID: 8624349
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast cancer and hormone-replacement therapy.
    Bluming AZ
    N Engl J Med; 1995 Nov; 333(20):1357; author reply 1357-8. PubMed ID: 7566037
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hormone replacement treatment and breast cancer].
    Comino Delgado R; Fernández-Alba JJ
    An R Acad Nac Med (Madr); 1999; 116(3):557-603. PubMed ID: 10846581
    [No Abstract]   [Full Text] [Related]  

  • 40. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
    Shapiro S
    Climacteric; 2003 Dec; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.